Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne

Northwestern University

Status and phase

Completed

Phase 4

Conditions

Acne

Treatments

Combination Product: Proactive Acne Regimen - other side of face

Combination Product: Geologie Acne Regimen - one side of face

Study type

Interventional

Funder types

Other

Identifiers

NCT05446402

STU#00217056

Details and patient eligibility

About

The objective of this study is to compare tolerability of two similar commercially available over the counter acne regimens (Geologie and Proactiv) in individuals with mild to moderate acne vulgaris over a 12-week daily treatment course.

Full description

Acne vulgaris is a common, chronic inflammatory skin disorder that originates in the pilosebaceous unit. Acne typically begins in adolescence and often continues into adulthood, with about 20% of cases resulting in scars or hyperpigmentation. It's estimated that acne affects about 85% of adolescents. Individuals who experience acne and acne scars tend to also experience a negative impact on their social and mental health, including depression, anxiety, and social withdrawal. Currently, topical solutions and lifestyle changes are the primary treatment for mild to moderate acne.

This study will evaluate and compare the efficacy of two over the counter products in treating individuals with mild to moderate acne: Geologie and ProActive. Both sets of products will be provided to Northwestern in identical, unlabeled bottles for the purpose of blinding.

Enrollment

29 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

18 years or older
No known active skin infection.
Presence of mild or moderate acne on face (clinical diagnosis or self-report)
Willingness to give written consent and comply with study procedures.

Exclusion criteria

Active skin infection.
Inability to understand instructions or procedures involved.
Known allergy to ingredient(s) in products being used for study.
Pregnant women, prisoners, and vulnerable populations.
Has a history of acute or chronic disease that may interfere with or increase the risk of study participation.
Has any dermatological disorder that may interfere with the accurate evaluation of the subject's facial appearance, based on the opinion of the investigator.